What caused the ALNOR.LS stock volume spike on 16 Mar 2026?

The spike was driven by **900.00** shares trading versus an average **3.00**, a **300.00x** increase. That pattern often reflects concentrated orders or a small number of participants, not broad retail activity. Watch for sustained higher volume as confirmation.

How does ALNOR.LS stock valuation compare with its sector?

ALNOR.LS shows **PE 2.28** versus a Real Estate sector average PE near **19.53** on EURONEXT. The large discount may indicate undervaluation or company-specific risks; investigate asset reports and balance-sheet detail before acting.

What are Meyka’s price forecasts for ALNOR.LS stock?

Meyka AI's forecast model projects **€0.50** (12-month), **€0.57** (3-year) and **€0.64** (5-year) for ALNOR.LS stock. These are model-based projections and not guarantees; implied 12-month upside is **21.95%** from **€0.41**.

Is ALNOR.LS stock liquid enough for trading strategies?

Historically no: avgVolume is **3.00** shares. The recent **900.00**-share session is an outlier. Low average liquidity increases execution and slippage risk for larger orders and short-term strategies.

EU Stocks

300x volume spike 16 Mar 2026: ALNOR.LS Nexponor (EURONEXT) signals liquidity shift

ByDanny Kontos March 17, 2026March 17, 2026

A sharp volume spike pushed attention to ALNOR.LS stock at market close on 16 Mar 2026. Trading finished at €0.41, with 900.00 shares changing hands versus an average volume of 3.00, a 300.00x jump that flagged renewed liquidity in the EURONEXT-listed Nexponor, SICAFI, S.A. The market was closed when we captured these figures. This note reviews the volume surge, underlying valuation metrics and how short-term traders and longer-term investors might read the signal.